AKT1 and hepatocellular carcinoma: Additionally, the study identified AKT1, EGFR, ALB, and TNF genes as potential targets for drug intervention, and p-cresol glucuronide, secoisolariciresinol, glycocholic acid, enterodiol, and citric acid as active inhibitors that could be effective in mitigating the risk factors associated with HCC.